Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Has announcements
×
Lymphoma, Non-Hodgkin
×
Lenalidomide
×
Clear all
Filters
3
NCT05409066
2025-07-28
EPCORE FL-1
Genmab
Phase 3
Active not recruiting
549 enrolled
2 FDA
NCT01996865
2025-07-10
MAGNIFY
Celgene
Phase 3
Completed
503 enrolled
18 charts
1 FDA
NCT01938001
2023-02-22
AUGMENT
Celgene
Phase 3
Completed
358 enrolled
18 charts
1 FDA